Testing effectiveness (Phase 2)Looking for participantsNCT06518005
What this trial is testing
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
Who this might be right for
Crigler-Najjar Syndrome
Genethon 3